These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27834822)

  • 1. Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients.
    Lorente L; Martín MM; Pérez-Cejas A; Barrios Y; Solé-Violán J; Ferreres J; Labarta L; Díaz C; Jiménez A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
    Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between serum interleukin-18 (IL-18) level, IL-18 gene promoter polymorphisms and the development of sepsis in children].
    Cai LL; Xiang W; Xie YQ; Liao F; Feng XW; Zhang DF; Chen YW; Zhang YM; Huang MJ; Zeng X
    Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):9-14. PubMed ID: 20441695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. -572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease.
    Panayides A; Ioakeimidou A; Karamouzos V; Antonakos N; Koutelidakis I; Giannikopoulos G; Makaritsis K; Voloudakis N; Toutouzas K; Rovina N; Bristianou M; Damoraki G; Routsi C; Giamarellos-Bourboulis EJ;
    Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2439-46. PubMed ID: 26463449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study.
    Lorente L; Martín MM; González-Rivero AF; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Jiménez A; Borreguero-León JM
    PLoS One; 2014; 9(10):e109618. PubMed ID: 25290885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
    Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tumor necrosis factor α -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis.
    Feng B; Mao ZR; Pang K; Zhang SL; Li L
    J Crit Care; 2015 Oct; 30(5):920-3. PubMed ID: 26025100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6.
    Tischendorf JJ; Yagmur E; Scholten D; Vidacek D; Koch A; Winograd R; Gressner AM; Trautwein C; Wasmuth HE; Lammert F
    Int J Immunogenet; 2007 Dec; 34(6):413-8. PubMed ID: 18001296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.
    Chakraborty B; Vishnoi G; Gowda SH; Goswami B
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e402-e407. PubMed ID: 25359504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
    Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis.
    Schlüter B; Raufhake C; Erren M; Schotte H; Kipp F; Rust S; Van Aken H; Assmann G; Berendes E
    Crit Care Med; 2002 Jan; 30(1):32-7. PubMed ID: 11902285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 -572C/G polymorphism is associated with serum interleukin-6 levels and risk of idiopathic pulmonary arterial hypertension.
    Fang M; Huang Y; Zhang Y; Ning Z; Zhu L; Li X
    J Am Soc Hypertens; 2017 Mar; 11(3):171-177. PubMed ID: 28229900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients.
    Accardo Palumbo A; Forte GI; Pileri D; Vaccarino L; Conte F; D'Amelio L; Palmeri M; Triolo A; D'Arpa N; Scola L; Misiano G; Milano S; Lio D
    Burns; 2012 Mar; 38(2):208-13. PubMed ID: 22079540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of an association between interleukin-6 -174G/C polymorphism and circulating interleukin-6 levels in normal population: a meta-analysis.
    Huang M; Wang L; Ma H; Wang J; Xiang M
    DNA Cell Biol; 2013 Nov; 32(11):654-64. PubMed ID: 24044580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
    Zhai K; Yang Y; Gao ZG; Ding J
    Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.
    Zakharyan R; Petrek M; Arakelyan A; Mrazek F; Atshemyan S; Boyajyan A
    Tissue Antigens; 2012 Aug; 80(2):136-42. PubMed ID: 22571276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis.
    He J; Chen Y; Lin Y; Zhang W; Cai Y; Chen F; Liao Q; Yin Z; Wang Y; Tao S; Lin X; Huang P; Cui L; Shao Y
    PLoS One; 2017; 12(5):e0176781. PubMed ID: 28472164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
    Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
    Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.
    Mahemuti A; Abudureheman K; Aihemaiti X; Hu XM; Xia YN; Tang BP; Upur H
    Chin Med J (Engl); 2012 Nov; 125(22):3997-4002. PubMed ID: 23158132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.